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A commentary on
Age-related neurodegenerative disease research needs aging models
by Johnson, I. P. (2015). Front. Aging Neurosci. 7:168. doi: 10.3389/fnagi.2015.00168
In his recent article, Ian Johnson identifies a need for research into neurodegenerative diseases
that makes use of animal models more closely resembling the complex, age-related reality of these
diseases in people (Johnson, 2015). The purpose of this commentary is to build upon this idea using
insights from animal and human models of frailty.
Johnson has highlighted the growing importance of finding suitable treatments for
neurodegenerative disorders as our population ages and these diseases become more common.
Current animal models of neurodegenerative disease largely ignore the context in which many
of these diseases arise; they are inextricably linked to aging. We argue that the process of aging
represents more than just the passage of time. As the author notes, “age at the time of neuronal
injury affects neuronal survival, so it is a small step to suggest that age-related differences in
neuronal survival requirements could explain the disappointing translation of basic research to
clinical situations” (Johnson, 2015). We would like to take the reader one step further to consider
the differences between young and old individuals. Specifically, we draw attention to the concept
that aging represents the accumulation of deficits in a complex system, such as a living organism. It
is hypothesized that subcellular deficits accumulate to eventually give rise to tissue level deficits and
continue to “scale up” to organ and system level deficits that are clinically recognizable (Howlett
and Rockwood, 2013; Rockwood et al., 2015).
The accumulation of health deficits has been used to measure a person’s level of frailty, which
can be conceptualized as a state of increased vulnerability to poor health outcomes that differs
among people of the same chronological age (Mitnitski et al., 2001; Rockwood and Mitnitski, 2007;
Clegg et al., 2013). In this way, among people who are the same age, different individuals have
differing levels of health and risk of death (Mitnitski et al., 2013). This difference in health state
can be characterized as the number of health deficits present in an individual; someone with 3
health problems is less likely to suffer adverse health events than someone with 10 health problems
(Mitnitski et al., 2001). Thus, frailty can be measured as the accumulation of deficits, and this
quantification has been shown to be valid and reliable across both human and, more recently,
rodent populations (Mitnitski et al., 2002, 2004; Goggins et al., 2005; Parks et al., 2012; Wallace
et al., 2014; Whitehead et al., 2014; Feridooni et al., 2015; Kane et al., 2015).
To truly understand the origins of (and thus, appropriately treat) age-associated
neurodegenerative disorders, we must consider them in the context in which they arise—in
aging organisms as Johnson has suggested. Identifying and modeling frailty may be useful in
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this endeavor. One of us (SH) has developed an approach
to modeling frailty in mice, allowing researchers to quantify
health deficits (Parks et al., 2012; Feridooni et al., 2015; Huizer-
Pajkos et al., 2015; Kane et al., 2015). Interestingly, mice exhibit
an exponential increase in frailty with age, with a pattern
that is remarkably similar to that seen in human populations
(Whitehead et al., 2014). Further, increased frailty is associated
with other adverse health effects, including poor heart cell
function in mice (Parks et al., 2012). Studies in mice have also
shown that frailty is attenuated by known longevity interventions
including caloric restriction and treatment with the anti-oxidant,
resveratrol (Kane et al., 2015).
Johnson presents some barriers to modeling aging in
mice, particularly that mice tend to acquire age-related health
problems, which may pose a threat to the quality and accuracy
of research. If we consider (1) that very few people with
neurodegenerative disease suffer from no other health problems,
and (2) the presence of multiple age-related conditions that
may be complex and inter-related create the exact conditions
we describe as characteristic of the aging process, this may
not serve as a barrier. To date, research on neurodegenerative
disease has largely ignored the fact that age-related conditions
come as a package in a complex system, the human body.
Thus, research conducted on young animals with few health
problems in attempts to isolate mechanisms may not be useful
for this particular research problem and could contribute to the
lack of translation we see in clinical trials. Given the research
efforts and funding devoted to understanding the mechanisms
and treatment of neurodegenerative diseases without major gain,
waiting 2–3 years for animals to age to acquire quality results
seems like a better alternative than doing research that does not
translate well to humans.
Another point we argue in considering how best to translate
research from animal models to humans, is to encourage the
inclusion of female animals in models simulating age-related
disease. Females are frequently excluded from studies because
effects of hormone cycles are considered to be a confounder,
although the evidence suggests that results obtained in females
are not inherently more variable than results in males (Clayton
and Collins, 2014). Further, the reality is that women live longer
than men and tend to suffer from age-related diseases at a
disproportionate rate. Including female animals may be another
way to improve the translational ability of animal models in
studies of aging.
Based on research to date, a single mechanism responsible
for each age-related disease is unlikely. Instead, it may be
useful to consider these problems as arising in complex,
interacting systems, and embrace the possibility that
these age-related diseases are of multiple origins. Aging
animal research can play a significant role in realizing this
aim, particularly in modeling disease among frail older
individuals. We applaud the author of the original editorial
for bringing this issue to light and hope that readers will
consider frailty in how we can bring about meaningful
change in animal modeling of age-related neurodegenerative
disease.
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